Global Hospital-Acquired Infection Control Market Research Report 2017 to 2021 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure of the Hospital-Acquired Infection Control Market.
Companies Mentioned are AstraZeneca, GlaxoSmithKline, Merck, Pfizer, 3M, Abbott Laboratories, AbbVie, Advanced Sterilization Products, Alere, Bayer, BD, bioMérieux, Cepheid, Getinge Group, Hoffmann La-Roche, Synergy Health, and Xenex.
The global Hospital-Acquired Infection Control market consists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.
Major points covered in Global Hospital-Acquired Infection Control Market 2017 Research are:-
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global Hospital-Acquired Infection Control market?
- What are the key market trends impacting the growth of the global Hospital-Acquired Infection Control market?
- What are the challenges to market growth?
- Who are the key vendors in the global Hospital-Acquired Infection Control market?
- What are the market opportunities and threats faced by the vendors in the global Hospital-Acquired Infection Control market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global Hospital-Acquired Infection Control market?
This independent 94 page report guarantees you will remain better informed than your competition. With over 150 tables and figures examining the Hospital-Acquired Infection Control market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2021.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Hospital-Acquired Infection Control in these regions, from 2012 to 2021 (forecast), covering Americas, APAC and EMEA.
Commenting on the report, an analyst from MIR’s team said: “One trend in the market is emergence of innovative techniques to remove biofilms. Biofilm refers to a collective layer of microorganisms that can form on the surface of a medical device or on any other area where a biological activity takes place. These layers attach to both biotic and abiotic surfaces. Hence, they can be found at the sites of HAIs.”
According to the report, one driver in the market is increasing innovative measures to prevent HAIs. With increasingly complex pathogens emerging in healthcare facilities and these microbes developing multiple antibiotic resistance, hospitals must use innovative methods to combat HAIs, which is a significant cost burden on the healthcare systems of countries. For instance, HAI infections cost approximately $35 billion annually in the US. Hence innovative measures are required to reduce the incidence of HAIs. The use of ultraviolet (UV) radiation to systematically disinfect hospitals is an innovative approach to control the prevalence of HAIs.
Further, the report states that one challenge in the market is emergence of antibiotic resistance. Antibiotic resistance refers to a microorganism becoming resistant to multiple antibiotics as it modifies itself when exposed to antimicrobial drugs. Microorganisms that develop resistance to antibiotics are referred to as superbugs. Improper hospital hygiene, unwanted or increased use of antibiotics, and emergence of genetic elements that adapt and enhance bacterial resistance mechanisms are the primary causes of antibiotic resistance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The report provides a basic overview of the Hospital-Acquired Infection Control industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Hospital-Acquired Infection Control industry development trends and marketing channels are analyzed.
The research includes historic data from 2012 to 2016 and forecasts until 2021 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Hospital-Acquired Infection Control on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Hospital-Acquired Infection Control Market and assist manufacturers and investment organization to better grasp the development course of Hospital-Acquired Infection Control Market.
Buy Full Report at: https://www.marketinsightsreports.com/report/purchase/07079033?mode=su